Omnicell (OMCL) Restructuring Costs (2010 - 2022)
Omnicell's (OMCL) quarterly Restructuring Costs came in at $3.5 million in Q1 2022, up 75.0% year-over-year from $2.0 million in Q1 2021, and up 75.0% quarter-over-quarter from $2.0 million in Q1 2021.
Powered by 
Analysis
Omnicell (OMCL) Restructuring Costs (2010 - 2022) Analysis & Trends
Omnicell (OMCL) has reported Restructuring Costs for 3 consecutive years, with $3.5 million the latest figure, recorded in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 3.50 Mn |
| Mar 31, 2021 | 2.00 Mn |
| Sep 30, 2010 | 1.20 Mn |